Rankings
▼
Calendar
AMRN Q2 2016 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$338M
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$33M
Gross Profit
$24M
73.2% margin
Operating Income
-$14M
-43.5% margin
Net Income
-$13M
-40.3% margin
EPS (Diluted)
$-1.45
QoQ Revenue Growth
+29.6%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$148M
Total Liabilities
$312M
Stockholders' Equity
-$164M
Cash & Equivalents
$72M
← FY 2016
All Quarters
Q3 2016 →